Cleared Special

K020767 - ADVANTA SST BIFURCATED GRAFT
(FDA 510(k) Clearance)

Apr 2002
Decision
26d
Days
Class 2
Risk

K020767 is an FDA 510(k) clearance for the ADVANTA SST BIFURCATED GRAFT. This device is classified as a Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (Class II - Special Controls, product code DSY).

Submitted by Atrium Medical Corp. (Hudson, US). The FDA issued a Cleared decision on April 3, 2002, 26 days after receiving the submission on March 8, 2002.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.3450.

Submission Details

510(k) Number K020767 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2002
Decision Date April 03, 2002
Days to Decision 26 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement

Device Classification

Product Code DSY — Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.3450

Similar Devices — DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

All 186
Spiral Laminar Flow? Vascular Arteriovenous Graft (AV0645)
K252277 · Vascular Flow Technologies Limited · Oct 2025
Gelweave? Vascular Prostheses
K241550 · Vascutek, Ltd. · Feb 2025
Gelsoft? Plus Vascular Prostheses
K241070 · Vascutek, Ltd. · Nov 2024
Advanta VXT Vascular Graft, Flixene Vascular Graft
K231972 · Atrium Medical Corporation · Mar 2024
GORE? PROPATEN? Vascular Graft
K240083 · W.L. Gore & Associates, Inc. · Mar 2024
exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts
K233783 · Peca Labs, Inc. · Jan 2024